Preferred Name |
Cangrelor |
|
Synonyms |
AR-C69931MX CANGRELOR Cangrelor |
|
Definitions |
An inhibitor of the platelet adenosine diphosphate (ADP) P2Y12 receptor (P2Y12R), with antiplatelet activity. Upon administration, cangrelor selectively and reversibly binds to P2Y12R, and blocks the platelet signaling pathway. This inhibits the activation of the glycoprotein complex GPIIb/IIIa, fibrinogen binding to platelets and platelet adhesion and aggregation. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C76395 |
|
CAS_Registry |
163706-06-7 |
|
Chemical_Formula |
C17H25Cl2F3N5O12P3S2 |
|
code |
C76395 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA HemOnc |
|
DEFINITION |
An inhibitor of the platelet adenosine diphosphate (ADP) P2Y12 receptor (P2Y12R), with antiplatelet activity. Upon administration, cangrelor selectively and reversibly binds to P2Y12R, and blocks the platelet signaling pathway. This inhibits the activation of the glycoprotein complex GPIIb/IIIa, fibrinogen binding to platelets and platelet adhesion and aggregation. |
|
FDA_UNII_Code |
6AQ1Y404U7 |
|
FULL_SYN |
AR-C69931MX CANGRELOR Cangrelor |
|
Has_Salt_Form | ||
label |
Cangrelor |
|
Legacy Concept Name |
Cangrelor |
|
Preferred_Name |
Cangrelor |
|
prefixIRI |
Thesaurus:C76395 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C1121991 |
|
subClassOf |